http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110330474-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
| filingDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110330474-B |
| titleOfInvention | Preparation of apigenin-dithiocarbamate derivative and anti-tumor application |
| abstract | The invention discloses a preparation method of apigenin-dithiocarbamate derivatives and application of the apigenin-dithiocarbamate derivatives in antitumor activity research. Shown as formula I, wherein n is 3. The compound can inhibit the proliferation of various tumor cells, shows good antiproliferative activity on 6 tested cancer cells, and is superior to pentafluorouracil. Among them, Q6 has the best antitumor effect and the most significant PC-3 cell inhibiting effect. |
| priorityDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.